Response rate profiles for major depressive disorder: Characterizing early response and longitudinal nonresponse
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Definition of response is critical when seeking to establish valid predictors of treatment success. However, response at the end of study or endpoint only provides one view of the overall clinical picture that is relevant in testing for predictors. The current study employed a classification technique designed to group subjects based on their rate of change over time, while simultaneously addressing the issue of controlling for baseline severity. METHODS: A set of latent class trajectory analyses, incorporating baseline level of symptoms, were performed on a sample of 344 depressed patients from a clinical trial evaluating the efficacy of cognitive behavior therapy and two antidepressant medications (escitalopram and duloxetine) in patients with major depressive disorder. RESULTS: Although very few demographic and illness-related features were associated with response rate profiles, the aggregated effect of candidate genetic variants previously identified in large pharmacogenetic studies and meta-analyses showed a significant association with early remission as well as nonresponse. These same genetic scores showed a less compelling relationship with endpoint response categories. In addition, consistent nonresponse throughout the study treatment period was shown to occur in different subjects than endpoint nonresponse, which was verified by follow-up augmentation treatment outcomes. CONCLUSIONS: When defining groups based on the rate of change, controlling for baseline depression severity may help to identify the clinically relevant distinctions of early response on one end and consistent nonresponse on the other.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 1×
“In particular, remission (Frank et al., 1991) has been identified as the goal of treatment for MDD due to its strong association with restoration of functioning and durability of wellness (Keller, 2004).”
BackgroundKeller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., Markowitz, J. C., Nemeroff, C. B., Russell, J. M., Thase, M. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422001 · Cited by 1,331 · cited 2×
“The slower response to CBT versus antidepressant medications has been previously reported (Keller et al., 2000); nevertheless, the overall efficacy of the treatments does not differ by the end of 12weeks of treatment.”
BackgroundSelf-citationKapur, S., Phillips, A. G., & Insel, T. R. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.105 · Cited by 980
Fava, M., Rush, A. J., Alpert, J. E., Balasubramani, G. K., Wisniewski, S. R., Carmin, C. N., Biggs, M. M., Zisook, S., Leuchter, A., Howland, R., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111868 · Cited by 927
Sudden gains and critical sessions in cognitive-behavioral therapy for depression.
Tang, T. Z., & DeRubeis, R. J. (1999) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.67.6.894 · Cited by 684
Toward a Neuroimaging Treatment Selection Biomarker for Major Depressive Disorder
McGrath, C. L., Kelley, M. E., Holtzheimer, P. E., Dunlop, B. W., Craighead, W. E., Franco, A. R., Craddock, R. C., & Mayberg, H. S. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.143 · Cited by 561 · cited 1×
“2018;35:992–1000.wileyonlinelibrary.com/journal/da Dunlop, Kelley, McGrath, Craighead, &Mayberg, 2015;McGrath et al., 2013; 2014).”
Self-citationSerretti, A., Kato, M., De Ronchi, D., & Kinoshita, T. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001926 · Cited by 529
The role of nonspecific factors in cognitive-behavior therapy for depression.
Ilardi, S. S., & Craighead, W. E. (1994) · Clinical Psychology: Science and Practice · doi:10.1111/j.1468-2850.1994.tb00016.x · Cited by 501
Self-citationReview and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
Kato, M., & Serretti, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.116 · Cited by 450
How Placebos Change the Patient's Brain
Benedetti, F., Carlino, E., & Pollo, A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.81 · Cited by 446
Cited by
Sforzini, L., Worrell, C., Kose, M., Anderson, I. M., Aouizerate, B., Arolt, V., Bauer, M., Baune, B. T., Blier, P., Cleare, A. J., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01381-x · Cited by 214
“In terms of ‘minimum duration’, some studies have shown that, while two weeks can be enough to observe an initial response, a stable response/remission is usually detectable after four weeks [37, 38].”
BackgroundSelf-citationDai, F., Wengler, K., He, X., Wang, J., Yang, J., Parsey, R. V., & DeLorenzo, C. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03292-9 · Cited by 12
Latent classes of symptom trajectories among major depressive disorder patients in China
Wang, Y., Li, J., Bian, W., Duan, Y., Geng, W., Jiang, J., Zhao, X., Li, T., Jiang, Y., Shi, L., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.144 · Cited by 5
Metadata
- Authors
- Kelley, M. E., Dunlop, B. W., Nemeroff, C. B., Lori, A., Carrillo-Roa, T., Binder, E. B., Kutner, M. H., Rivera, V. A., Craighead, W. E., & Mayberg, H. S.
- Venue
- Depression and Anxiety
- Publisher
- Wiley
- Published
- 2018-09-07
- Volume
- 35
- Issue
- 10
- Pages
- 992-1000
- ISSN
- 1091-4269 (ISSN-L)
- OpenAlex
- W2892026058
- Cited by
- 43
- References
- 24
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.